رجوع
32
نطاق اليوم
KWD 24.20
KWD 26.30
نطاق 52 أسبوعًا
KWD 24.20
KWD 34.00
حجم التداول
1,100
متوسط 50 يوم / 200 يوم
KWD 26.72
/
KWD 29.11
الإغلاق السابق
KWD 24.20
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 43.3 | 0.4 |
| P/B | 2.5 | 2.9 |
| ROE % | 5.9 | 3.8 |
| Net Margin % | 9.6 | 3.9 |
| Rev Growth 5Y % | 28.4 | 10.0 |
| D/E | 0.1 | 0.2 |
النقاط الرئيسية
Revenue grew 28.44% annually over 5 years — strong growth
Earnings grew 68.02% over the past year
Debt/Equity of 0.09 — conservative balance sheet
Generating 59.41M in free cash flow
P/E of 43.27 — premium valuation
PEG of 0.82 suggests growth is underpriced
النمو
Revenue Growth (5Y)
28.44%
Revenue (1Y)8.66%
Earnings (1Y)68.02%
FCF Growth (3Y)-14.45%
الجودة
Return on Equity
5.90%
ROIC5.13%
Net Margin9.56%
Op. Margin12.28%
الأمان
Debt / Equity
0.09
Current Ratio0.66
Interest Coverage8.75
التقييم
P/E Ratio
43.27
P/B Ratio2.52
EV/EBITDA32.73
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8.66% | Revenue Growth (3Y) | 8.71% |
| Earnings Growth (1Y) | 68.02% | Earnings Growth (3Y) | 45.94% |
| Revenue Growth (5Y) | 28.44% | Earnings Growth (5Y) | 11.10% |
| Profitability | |||
| Revenue (TTM) | 205.66M | Net Income (TTM) | 19.66M |
| ROE | 5.90% | ROA | 3.57% |
| Gross Margin | 87.17% | Operating Margin | 12.28% |
| Net Margin | 9.56% | Free Cash Flow (TTM) | 59.41M |
| ROIC | 5.13% | FCF Growth (3Y) | -14.45% |
| Safety | |||
| Debt / Equity | 0.09 | Current Ratio | 0.66 |
| Interest Coverage | 8.75 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 43.27 | P/B Ratio | 2.52 |
| P/S Ratio | 4.14 | PEG Ratio | 0.82 |
| EV/EBITDA | 32.73 | Dividend Yield | 0.01% |
| Market Cap | 850.72M | Enterprise Value | 826.46M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 205.66M | 189.27M | 174.02M | 165.54M | 75.58M |
| Net Income | 19.66M | 11.70M | 9.23M | 9.41M | 12.91M |
| EPS (Diluted) | 0.55 | 0.33 | 0.26 | 0.27 | 0.48 |
| Gross Profit | 179.27M | 162.20M | 122.71M | 103.44M | 66.71M |
| Operating Income | 25.25M | 19.73M | 19.23M | 18.13M | 13.24M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 551.06M | 543.66M | 583.33M | 574.64M | 311.88M |
| Total Liabilities | 213.50M | 215.06M | 256.02M | 240.89M | 51.60M |
| Shareholders' Equity | 337.56M | 328.59M | 327.31M | 333.75M | 260.28M |
| Total Debt | 31.65M | 40.15M | 86.55M | 115.78M | 2.20M |
| Cash & Equivalents | 55.92M | 34.59M | 78.41M | 48.51M | 235.62M |
| Current Assets | 119.59M | 93.23M | 113.96M | 87.99M | 253.60M |
| Current Liabilities | 181.11M | 148.76M | 127.38M | 78.08M | 49.41M |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#773 of 1024
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026